{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260406252364/en/Gilead-to-Acquire-Tubulis-Adding-Potentially-Best-in-Class-Antibody-Drug-Conjugate-and-Next-Generation-Platform-to-Further-Strengthen-Oncology-Pipeline", "message": "News view counter 650923 successfully enlarged"}